NCT03445117

Increasing the Uptake of Influenza and Pneumococcal Vaccines Among High-Risk Adult Patients Through GP Clinics

Completed NA Last updated 5 July 2019

What this trial tests

NA trial testing Educational intervention in Immunization Programs in 8,837 participants. Completed in 31 July 2018.

Timeline

1 November 2017

Primary endpoint
31 July 2018

31 July 2018

Quick facts

Lead sponsor	Tan Tock Seng Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	none
Primary purpose	health services research
Enrollment	8,837
Start date	1 November 2017
Primary completion	31 July 2018
Estimated completion	31 July 2018
Sites	2 locations across Singapore

Drugs / interventions tested

• Educational intervention

Conditions studied

• Immunization Programs — all drugs for Immunization Programs →

Sponsor

Tan Tock Seng Hospital

Who can join

65 and older, any sex, with Immunization Programs. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Pneumonia and influenza are among the top causes of hospitalisation and death in the elderly. While vaccinations are recommended against these diseases, a large proportion of elderly in the community remain unvaccinated, with approximately only 10% vaccinated for either disease. In this study, the investigators aim to implement an intervention package within GP clinics to increase influenza and pneumococcal vaccination rates, especially among elderly patients with chronic diseases.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

1. Increasing Influenza and Pneumococcal Vaccination Uptake in Seniors Using Point-of-Care Informational Interventions in Primary Care in Singapore: A Pragmatic, Cluster-Randomized Crossover Trial.
   Ho HJ, Tan YR, Cook AR, Koh G, et al · · 2019 · cited 37× · PMID 31622142 · DOI 10.2105/ajph.2019.305328